CardioVascular BioTherapeutics has signed a collaborative R&D agreement with global clinical contract research organization bioRASI to initiate proof of concept clinical studies in patients with …
BIO-012 - CARDIOVASCULAR DISEASE - Novel Pharmacological Approach for the Control of Homocysteine Levels in Patients with End-Stage Renal DiseaseDetails Project Title BIO-012 - CARDIOVASCULAR …